BioSpace News Archive

Canopy Growth Corporatio and its subsidiary, Bedrocan Canada Inc. (“BC”) are pleased to announce that they have reached an agreement (the “Agreement”) with Bedrocan International BV

Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage drug discovery and development company applying synthetic biology to probiotics to develop novel living medicines, today announced the presentation of preclinical data from SYNB1618, an investigational Synthetic Biotic medicine currently being evaluated in an ongoing Phase 1/2a clinical trial in healthy volunteers and patients with PKU.

Varian announced that it will report results for the third quarter of fiscal year 2018 after market close on Wednesday, July 25, 2018.

Enzo Biochem Inc. reported results for the third fiscal quarter and nine months ended April 30, 2018

Conference and live webcast call scheduled for 8:00 AM Eastern Time, Tuesday June 12

CryoLife, Inc. announces the publication of our clinical study entitled “Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement” in a peer-reviewed medical journal, the Journal of the American College of Cardiology.

IQVIA Inc. announced that it has placed approximately $1.65 billion of USD and EUR term B loans

Group Asserts Action Shows Progress toward Policy Change in Future

Kadmon Holdings, Inc. announced the pricing of an offering of an aggregate of 30,303,030 shares of its common stock at an offering price of $3.30 per share

Company confident that COPAN complaint is without merit and will vigorously defend its product rights